Patent ID: 7615567

Claim:
A method of treating Tourette's syndrome, comprising administering to a patient in need thereof an effective amount of a compound represented by formula (II): wherein A 3 is —R, —N(R) 2 , —C(═NR)N(R) 2 , or —OR; each Q is, independently, C—X or N, wherein one Q is N and each other Q is C—X; each X is, independently, H, halogen, alkyl, alkenyl, alkynyl, aryl, aralkyl, —OH, —OR, —CH 2 —CO 2 R, —CO—R, —CO 2 R, —N(R) 2 , —NR—CO—R, —CO—N(R) 2 , —NRCO 2 R, —SO 3 CF 3 , —NO 2 , —N 3 , —CF 3 , —CH═CHY, or —CN, with the proviso that at least one X is represented by the formula: each S is, independently, halogen, alkyl, alkenyl, alkynyl, phenyl, aralkyl, —OH, —OR, —CH 2 —CO 2 R, —CO—R, —CO 2 R, —N(R) 2 , —NR—CO—R, —CO—N(R) 2 , —NRCO 2 R, —SO 3 CF 3 , —NO 2 , —N 3 , —CF 3 , —CH═CHY, or —CN, or two S, taken together with the phenyl group to which they are bonded, form a 2-naphthyl group; c is 1,2,3,4 or 5; Y is a halogen; and each R is, independently, H, alkyl, alkenyl, alkynyl, aryl, or aralkyl; or a pharmaceutically acceptable salt thereof.